Corient Capital Partners’s Sanofi SNY Stock Holding History

Corient Capital Partners’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$422K	Hold	8,436	–	–	0.03%	376
2022 Q2	$422K	Sell	8,436 -7	-0.1%	-$372	0.03%	386
2022 Q1	$433K	Buy	8,443 +668	+9%	+$34.5K	0.03%	416
2021 Q4	$390K	Buy	7,775 +2,655	+52%	+$131K	0.03%	435
2021 Q3	$247K	Buy	5,120 +128	+3%	+$6.51K	0.02%	563
2021 Q2	$263K	Buy	+4,992	New	+$260K	0.02%	529
2020 Q4	–	Sell	-4,946	Closed	-$248K	–	557
2020 Q3	$248K	Buy	4,946 +19	+0.4%	+$978	0.03%	386
2020 Q2	$252K	Sell	4,927 -461	-9%	-$22.4K	0.03%	379
2020 Q1	$236K	Sell	5,388 -1,312	-20%	-$62.8K	0.04%	335
2019 Q4	$336K	Buy	6,700 +661	+11%	+$31K	0.04%	336
2019 Q3	$280K	Buy	+6,039	New	+$260K	0.04%	353

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Corient Capital Partners's SNY Position: Q3 2022 in Review

Corient Capital Partners held its Sanofi (SNY) position steady in Q3 2022 at 8,436 shares worth $422K. The position accounts for 0.03% of the portfolio, ranked #376.

Corient Capital Partners first reported a position in SNY in Q3 2019 and has held it in 11 quarters since. The position peaked at $433K in Q1 2022. 587 funds tracked by Wall St. Rank hold SNY as of Q3 2022.

Corient Capital Partners held 8,436 shares of Sanofi worth $422K as of Q3 2022.
Corient Capital Partners left its Sanofi share count unchanged in Q3 2022.
Sanofi made up 0.03% of Corient Capital Partners's portfolio in Q3 2022, its #376 holding.
Corient Capital Partners first reported a position in Sanofi in Q3 2019 and has held it in 11 quarters since.
Corient Capital Partners's Sanofi position peaked at $433K in Q1 2022.
587 funds tracked by Wall St. Rank held Sanofi as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.